Today: 7 February 2026
Subscribe
Browse Category

Analyst Insights News 22 December 2025

Palo Alto Networks (PANW) Stock News Today: Google Cloud’s Near-$10 Billion Deal, AI-Security Momentum, and Analyst Forecasts (Dec. 22, 2025)

Palo Alto Networks (PANW) Stock News Today: Google Cloud’s Near-$10 Billion Deal, AI-Security Momentum, and Analyst Forecasts (Dec. 22, 2025)

Palo Alto Networks, Inc. (NASDAQ: PANW) is back in the spotlight on December 22, 2025, as investors digest a wave of fresh coverage and analysis tied to the company’s expanding role in AI-era cybersecurity—and a landmark cloud partnership that could reshape its growth narrative into 2026. As of the latest available quote on Dec. 22, PANW traded around $189.65, up roughly 1.5% on the day, as the market continued to assess the revenue potential (and execution risks) of several major strategic moves. Below is a comprehensive, publication-ready roundup of the current news, forecasts, and analyses circulating today (22.12.2025)—including what’s driving
22 December 2025
·····
Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen Inc. (NASDAQ: AMGN) is back in the spotlight on Monday, December 22, 2025, as investors weigh a wave of White House drug‑pricing agreements, a fast‑moving “most‑favored‑nation” (MFN) pricing push, and what it could all mean for Amgen’s earnings power in 2026. The stock traded higher in Monday’s session, with market data showing shares around $331. While the headlines are centered on drug prices, the market’s reaction has been notably measured: several analyst notes published today suggest these deals may be designed to reduce political and tariff uncertainty more than they materially compress pharma profits—at least in the near term.
22 December 2025
·····
Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Dec. 22, 2025 — Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) is stepping into a new tier of market visibility today as its Nasdaq-100 Index membership takes effect ahead of the opening bell—an index catalyst that can influence near-term trading and broaden long-term institutional ownership. Nasdaq+1 ALNY was trading around $405.60 on Dec. 22 (time-stamped 16:37 UTC), up about 1.3% versus the prior close—an incremental move that nonetheless lands in the middle of a busier-than-usual news cycle for the RNAi leader. Below is a comprehensive roundup of the current news, forecasts, and market analysis circulating through Dec. 22, 2025, and what investors
22 December 2025
·····
Tesla Stock (TSLA) News Today (Dec. 22, 2025): Musk Pay Package Ruling, Robotaxi Momentum, Analyst Forecasts, and the Key Risks Ahead

Tesla Stock (TSLA) News Today (Dec. 22, 2025): Musk Pay Package Ruling, Robotaxi Momentum, Analyst Forecasts, and the Key Risks Ahead

Tesla, Inc. stock (NASDAQ: TSLA) is trading near record territory on Monday, December 22, 2025, as investors weigh a fresh wave of autonomy hype against very real legal, regulatory, and demand headwinds. At the center of today’s move: the Delaware Supreme Court decision restoring Elon Musk’s 2018 Tesla compensation plan—now valued at roughly $139 billion—plus ongoing headlines around Tesla’s robotaxi testing narrative. Reuters+1 As of 15:14 UTC, TSLA was at $487.66, up about 1.34% on the day after touching an intraday high of $498.70. Below is what’s driving Tesla stock today, what analysts are forecasting into year-end and early 2026,
22 December 2025
·····
Comfort Systems USA (FIX) Stock News Today: S&P 500 Addition, Analyst Price Targets, and the 2026 Outlook

Comfort Systems USA (FIX) Stock News Today: S&P 500 Addition, Analyst Price Targets, and the 2026 Outlook

December 22, 2025 — Comfort Systems USA, Inc. (NYSE: FIX) is in the spotlight to start the week as the commercial HVAC and electrical contractor officially joins the S&P 500, a move that typically boosts visibility and can trigger near-term index-fund demand. News Release Archive As of Monday’s session, FIX stock traded around $958.80, up about 1.9% on the day, after opening near $958.60 and moving between roughly $940.00 and $959.83. The company’s market capitalization is about $34.3 billion, and the shares are roughly 7.5% below their 52‑week high of $1,036.66. Below is a detailed, publication-ready roundup of the latest
22 December 2025
·····
Comcast Stock (CMCSA) Today: Versant Spinoff Countdown, Dividend Outlook, and Analyst Forecasts for Dec. 22, 2025

Comcast Stock (CMCSA) Today: Versant Spinoff Countdown, Dividend Outlook, and Analyst Forecasts for Dec. 22, 2025

Comcast Corporation (NASDAQ: CMCSA) is ending 2025 in “transition mode”—and the market is treating it that way. On Monday, December 22, 2025, CMCSA shares traded around $29.70, up about 0.4% on the day after opening near $29.49, with an intraday range roughly between $29.46 and $29.78. That small price move doesn’t mean “nothing’s happening.” Comcast has a stack of near-term catalysts—most notably the Versant Media Group spinoff that will reshape Comcast’s footprint in early 2026—plus fresh operational headlines landing today, and a steady drumbeat of Wall Street target-price debate. Below is a comprehensive roundup of the current news, forecasts, and
22 December 2025
·····
Amicus Therapeutics (FOLD) Stock News Today: BioMarin’s $14.50 Buyout, Fresh Analyst Forecasts, and Key Dates to Watch (Dec. 22, 2025)

Amicus Therapeutics (FOLD) Stock News Today: BioMarin’s $14.50 Buyout, Fresh Analyst Forecasts, and Key Dates to Watch (Dec. 22, 2025)

Amicus Therapeutics, Inc. (NASDAQ: FOLD) stock is no longer trading like a typical biotech momentum name—at least not this week. As of December 22, 2025, the stock is hovering around $14.18, tightly anchored to the $14.50 per-share all-cash buyout BioMarin Pharmaceutical has agreed to pay. Investing.com+1 That tight range is the market’s way of saying: “We believe the deal is real, but not free money.” The remaining gap between today’s trading price and the $14.50 cash consideration reflects the time value of waiting, plus the risk (however small) that something delays or disrupts closing. Below is a full, publication-ready breakdown
22 December 2025
······
Planet Labs PBC (PL) Stock Today: December 22, 2025 News, Forecasts, and Analyst Takeaways After the Rally

Planet Labs PBC (PL) Stock Today: December 22, 2025 News, Forecasts, and Analyst Takeaways After the Rally

Planet Labs PBC (NYSE: PL) is starting December 22, 2025 near record territory after a month of headline catalysts that blended three powerful themes investors can’t resist: defense demand, AI-enabled data, and improving financial momentum. In premarket trading, PL was quoted around $19.79 early Monday, after a $19.18 prior close—levels that keep the stock close to recent highs and firmly on traders’ radar. MarketWatch+1 Today’s conversation around Planet Labs stock is less about “What does the company do?” and more about “How far can this rerating go—and what fundamentals need to show up next to justify it?” Why Planet Labs
22 December 2025
·····
Pan American Silver (PAAS) Stock: Latest News, Analyst Forecasts, and What to Watch as Silver Hits New Records (Dec. 22, 2025)

Pan American Silver (PAAS) Stock: Latest News, Analyst Forecasts, and What to Watch as Silver Hits New Records (Dec. 22, 2025)

Pan American Silver Corp. (NYSE: PAAS; TSX: PAAS) is closing out 2025 at the intersection of two powerful forces: a once-in-a-generation precious-metals rally and a company-specific growth reset after its MAG Silver acquisition. On Monday, December 22, 2025, that setup is back in the spotlight as gold and silver push into fresh record territory amid expectations for U.S. rate cuts and ongoing safe-haven demand—conditions that typically amplify interest in large, liquid precious-metals miners. Reuters+2The Times+2 Below is a full, up-to-date breakdown of today’s PAAS stock action, the most recent Pan American Silver corporate news, and the latest analyst targets and
22 December 2025
·····
Rio Tinto plc Stock (RIO): December 22, 2025 News, Commodity Tailwinds, Analyst Forecasts and Key Risks Investors Are Watching

Rio Tinto plc Stock (RIO): December 22, 2025 News, Commodity Tailwinds, Analyst Forecasts and Key Risks Investors Are Watching

Rio Tinto plc stock is heading into the final stretch of 2025 with a familiar recipe powering sentiment: firmer commodity prices, a year-end rally in miners, and a renewed corporate strategy pitch centered on simplification, cost discipline, and copper growth. On Monday, December 22, 2025, miners helped push Australia’s market to its strongest close in more than a month, with Rio Tinto shares rising alongside BHP and Fortescue on improved iron ore and copper pricing. The Economic Times Meanwhile, London-traded Rio Tinto plc (RIO.L) also firmed, with price data showing a 1.33% gain to about 5,915.9p on the day. Investing.com
22 December 2025
······
Reliance Industries Share Price Today (Dec 22, 2025): RIL Stock Near 52-Week High as Analysts Turn Bullish on 2026 Catalysts

Reliance Industries Share Price Today (Dec 22, 2025): RIL Stock Near 52-Week High as Analysts Turn Bullish on 2026 Catalysts

Reliance Industries Limited (NSE: RELIANCE, BSE: 500325) is trading near its 52-week peak on Monday, December 22, 2025, with the stock hovering around ₹1,568–₹1,572 by midday—modestly higher on the day, but sitting on a bigger story: December has delivered a rapid-fire run of upgrades, broker targets, and strategic headlines spanning AI, consumer brands, telecom monetisation, energy policy, and refining economics. The Economic Times+2Moneycontrol+2 With Indian benchmarks climbing in broad-based buying (supported by a rupee rebound and foreign inflows), Reliance’s steady grind higher is being treated by many desks as a “quality large-cap” way to play a potential year-end move—while keeping
22 December 2025
······
CSL Limited (ASX:CSL) Stock Update: Share Price, Buyback Progress, Analyst Forecasts and Key Catalysts as of 22 December 2025

CSL Limited (ASX:CSL) Stock Update: Share Price, Buyback Progress, Analyst Forecasts and Key Catalysts as of 22 December 2025

CSL Limited shares were trading around A$176 on 22 December 2025, modestly higher on the session but still nursing a steep 2025 decline that has kept the biotech heavyweight under intense investor scrutiny heading into 2026. Investing.com+2MarketWatch+2 The story around CSL stock (ASX:CSL) right now is a tug-of-war: ongoing confidence in the company’s global plasma and specialty therapies franchise versus uncertainty around its vaccine unit Seqirus, shifting guidance, and the execution risk of a major strategic reset. At the same time, CSL’s on‑market buyback has been a steady presence in daily announcements, offering a tangible signal of capital management even
22 December 2025
·····
1 … 12 13 14 15 16 … 29

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop